Web Analytics

3 Latest Announced Rounds

  • $26,000,000
    Series B

    5 Investors

    Computer Hardware Manufacturing
    May 15th, 2026
  • Undisclosed Amount
    Seed

    1 Investors

    Food and Beverage Manufacturing
    May 15th, 2026
  • $8,300,000
    Seed

    6 Investors

    Software Development
    May 15th, 2026
$847.85M Raised in 38 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Vaxinano

start up
France - Loos, Hauts-de-France
  • 30/10/2024
  • Unknown
  • $6,503,959

Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.

The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...


Related People